AquaBounty to Convert All Preferred Into Common; 8.08M Shares Expected by Oct 30 2026
AquaBounty Technologies (AQB) will convert all Series A and B preferred shares into 8.08M common shares by Oct 30, 2026. Conversion prices are $0.9129 for Series A and $1.03 for Series B. The move aims to simplify capital structure and increase common share float. AQB will file a Form S-3 for resale registration.
How this was made
The 30-second read
Why it matters
The conversion will increase the common share count by over 8 million, potentially diluting existing shareholders and putting downward pressure on the stock price, while also improving float and liquidity.
Market read
The corporate action directly affects AQB's share supply and could influence biotech sector sentiment, but broader market impact is limited.
What to watch
Potential tax benefits for preferred holders and the removal of dividend accruals after Oct 15 2026.
Background
AquaBounty Technologies filed an 8‑K detailing agreements to automatically convert its Series A and B preferred stock into common shares, aiming to simplify its capital structure.
Ticker impact
AquaBounty announced automatic conversion of all Series A and B preferred shares into common, issuing 8,077,043 new common shares.
likely downward pressure as market prices in dilution from the new common shares
Conversion adds over 8M shares, expanding supply and potentially reducing share price.
Market effects
The dilution may pressure other biotech stocks with similar capital structures.
Limited to U.S. markets where AQB trades; no broader regional effect expected.
Minimal global impact beyond investors tracking biotech corporate actions.
Counterpoint
The conversion could improve liquidity and attract new investors, offsetting dilution concerns.
Key entities
- CompanyAquaBounty Technologies Inc.
Biotech firm focused on aquaculture genetics, ticker AQB.
- StakeholderSeries A Preferred Holders
Holders of AQB Series A convertible preferred stock.
- StakeholderSeries B Preferred Holders
Holders of AQB Series B convertible preferred stock.